Danaher Corporation (DHR) has announced its projections for the first quarter of 2025, expecting a year-over-year decline in non-GAAP core revenue in the low-single-digit range. However, for the entire year of 2025, the corporation anticipates a year-over-year increase of approximately 3% in non-GAAP core revenue.
CEO Rainer Blair expressed optimism about the company's future, stating, "As we look forward, we believe Danaher is at its strongest in our 40-year history. The strategic transformation of our portfolio over recent years has positioned us as a focused innovator in life sciences and diagnostics, ready for sustained long-term growth, enhanced margins, and robust cash flow."
In the fourth quarter, Danaher reported earnings of $1.09 billion, or $1.49 per share, which compares to $1.08 billion, or $1.45 per share, from the previous year. The company's non-GAAP adjusted net earnings per share came in at $2.14, slightly below the analysts' average expectation of $2.16 per share, which typically excludes special items. Fourth-quarter revenues rose by 2.0% year-over-year to $6.5 billion, with non-GAAP core revenue climbing 1.0%.
As of pre-market trading on Wednesday, Danaher's shares have declined by 3%.
